{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T12:42:39Z","timestamp":1792154559751,"version":"4.4.0"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,7,17]],"date-time":"2019-07-17T00:00:00Z","timestamp":1563321600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","epilepsybehavior.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy & Behavior"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.yebeh.2019.07.007","type":"journal-article","created":{"date-parts":[[2019,8,5]],"date-time":"2019-08-05T11:43:13Z","timestamp":1565005393000},"page":"233-237","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"special_numbering":"PA","title":["The safety, tolerability, and effectiveness of PTL-101, an oral cannabidiol formulation, in pediatric intractable epilepsy: A phase II, open-label, single-center study"],"prefix":"10.1016","volume":"98","author":[{"given":"Alexis","family":"Mitelpunkt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uri","family":"Kramer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moran","family":"Hausman Kedem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Efrat","family":"Zilbershot Fink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rotem","family":"Orbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronika","family":"Chernuha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aviva","family":"Fattal-Valevski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Deutsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daphna","family":"Heffetz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hagit","family":"Sacks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.yebeh.2019.07.007_bb0005","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1542\/peds.2010-1371","article-title":"A national profile of childhood epilepsy and seizure disorder","volume":"129","author":"Russ","year":"2012","journal-title":"Pediatrics."},{"issue":"1","key":"10.1016\/j.yebeh.2019.07.007_bb0010","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/S0887-8994(97)00154-9","article-title":"Epidemiology of epilepsy in childhood: a cohort of 440 consecutive patients","volume":"18","author":"Kramer","year":"1998","journal-title":"Pediatr Neurol"},{"issue":"5","key":"10.1016\/j.yebeh.2019.07.007_bb0015","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1056\/NEJM200002033420503","article-title":"Early identification of refractory epilepsy","volume":"342","author":"Kwan","year":"2000","journal-title":"N Engl J Med"},{"issue":"26","key":"10.1016\/j.yebeh.2019.07.007_bb0020","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1056\/NEJMoa0911610","article-title":"Long-term mortality in childhood-onset epilepsy","volume":"363","author":"Sillanpaa","year":"2010","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.yebeh.2019.07.007_bb0025","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.yebeh.2013.04.016","article-title":"SUDEP and other causes of mortality in childhood-onset epilepsy","volume":"28","author":"Sillanpaa","year":"2013","journal-title":"Epilepsy Behav"},{"issue":"2","key":"10.1016\/j.yebeh.2019.07.007_bb0030","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.spen.2016.06.003","article-title":"Emerging antiepileptic drugs for severe pediatric epilepsies","volume":"23","author":"Mudigoudar","year":"2016","journal-title":"Semin Pediatr Neurol"},{"issue":"Pt B","key":"10.1016\/j.yebeh.2019.07.007_bb0035","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.yebeh.2016.09.040","article-title":"Cannabis and epilepsy: an ancient treatment returns to the fore","volume":"70","author":"Russo","year":"2017","journal-title":"Epilepsy Behav"},{"issue":"6","key":"10.1016\/j.yebeh.2019.07.007_bb0040","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1111\/epi.12631","article-title":"Cannabidiol: pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders","volume":"55","author":"Devinsky","year":"2014","journal-title":"Epilepsia."},{"key":"10.1016\/j.yebeh.2019.07.007_bb0045","article-title":"Cannabinoids for epilepsy","volume":"3","author":"Gloss","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"issue":"11","key":"10.1016\/j.yebeh.2019.07.007_bb0050","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1056\/NEJMra1407304","article-title":"Cannabinoids in the treatment of epilepsy","volume":"373","author":"Friedman","year":"2015","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.yebeh.2019.07.007_bb0055","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1002\/cpt1976193300","article-title":"Influence of cannabidiol on delta-9-tetrahydrocannabinol effects","volume":"19","author":"Dalton","year":"1976","journal-title":"Clin Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.yebeh.2019.07.007_bb0060","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/0014-2999(74)90129-0","article-title":"Cannabidiol interferes with the effects of delta 9 - tetrahydrocannabinol in man","volume":"28","author":"Karniol","year":"1974","journal-title":"Eur J Pharmacol"},{"issue":"Pt B","key":"10.1016\/j.yebeh.2019.07.007_bb0065","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.yebeh.2016.11.012","article-title":"Cannabinoids in treatment-resistant epilepsy: a review","volume":"70","author":"O'Connell","year":"2017","journal-title":"Epilepsy Behav"},{"issue":"4","key":"10.1016\/j.yebeh.2019.07.007_bb0070","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1007\/BF00450585","article-title":"Toward drugs derived from cannabis","volume":"65","author":"Mechoulam","year":"1978","journal-title":"Naturwissenschaften."},{"issue":"3","key":"10.1016\/j.yebeh.2019.07.007_bb0075","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1159\/000137430","article-title":"Chronic administration of cannabidiol to healthy volunteers and epileptic patients","volume":"21","author":"Cunha","year":"1980","journal-title":"Pharmacology."},{"key":"10.1016\/j.yebeh.2019.07.007_bb0080","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.seizure.2016.01.004","article-title":"CBD-enriched medical cannabis for intractable pediatric epilepsy: the current Israeli experience","volume":"35","author":"Tzadok","year":"2016","journal-title":"Seizure."},{"issue":"3","key":"10.1016\/j.yebeh.2019.07.007_bb0085","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/S1474-4422(15)00379-8","article-title":"Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial","volume":"15","author":"Devinsky","year":"2016","journal-title":"Lancet Neurol"},{"issue":"7","key":"10.1016\/j.yebeh.2019.07.007_bb0090","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1056\/NEJMc1708349","article-title":"Trial of cannabidiol for drug-resistant seizures in the Dravet syndrome","volume":"377","author":"Devinsky","year":"2017","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.yebeh.2019.07.007_bb0095","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/j.1600-0528.1993.tb00725.x","article-title":"Effects of cannabis smoking on oral soft tissues","volume":"21","author":"Darling","year":"1993","journal-title":"Community Dent Oral Epidemiol"},{"issue":"2","key":"10.1016\/j.yebeh.2019.07.007_bb0100","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/bms.1200130206","article-title":"Single-dose kinetics of deuterium-labelled cannabidiol in man after smoking and intravenous administration","volume":"13","author":"Ohlsson","year":"1986","journal-title":"Biomed Environ Mass Spectrom"},{"issue":"8","key":"10.1016\/j.yebeh.2019.07.007_bb0105","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1002\/cbdv.200790152","article-title":"Human cannabinoid pharmacokinetics","volume":"4","author":"Huestis","year":"2007","journal-title":"Chem Biodivers"},{"issue":"1","key":"10.1016\/j.yebeh.2019.07.007_bb0110","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1373\/clinchem.2010.152439","article-title":"Plasma cannabinoid pharmacokinetics following controlled oral delta9-tetrahydrocannabinol and oromucosal cannabis extract administration","volume":"57","author":"Karschner","year":"2011","journal-title":"Clin Chem"},{"issue":"7","key":"10.1016\/j.yebeh.2019.07.007_bb0115","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1002\/cpdd.408","article-title":"Single-dose pharmacokinetics of oral cannabidiol following administration of PTL101: a new formulation based on gelatin matrix pellets technology","volume":"7","author":"Atsmon","year":"2018","journal-title":"Clin Pharmacol Drug Dev"},{"issue":"8","key":"10.1016\/j.yebeh.2019.07.007_bb0120","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1111\/epi.13060","article-title":"Drug-drug interaction between clobazam and cannabidiol in children with refractory epilepsy","volume":"56","author":"Geffrey","year":"2015","journal-title":"Epilepsia."},{"issue":"7","key":"10.1016\/j.yebeh.2019.07.007_bb0125","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.braindev.2018.03.013","article-title":"Efficacy of CBD-enriched medical cannabis for treatment of refractory epilepsy in children and adolescents - an observational, longitudinal study","volume":"40","author":"Hausman-Kedem","year":"2018","journal-title":"Brain Dev"}],"container-title":["Epilepsy & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505019303051?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505019303051?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T18:27:41Z","timestamp":1761503261000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525505019303051"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":25,"alternative-id":["S1525505019303051"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2019.07.007","relation":{},"ISSN":["1525-5050"],"issn-type":[{"value":"1525-5050","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The safety, tolerability, and effectiveness of PTL-101, an oral cannabidiol formulation, in pediatric intractable epilepsy: A phase II, open-label, single-center study","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yebeh.2019.07.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}